Notice of Special General Meeting in Vostok Nafta

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Notice of Special General Meeting in Vostok Nafta Investment Ltd

Stockholm, 2013-09-27 08:00 CEST (GLOBE NEWSWIRE) --

Notice is hereby given to the holders of depository receipts in respect of shares in Vostok Nafta Investment Ltd (the “Company”) that a Special General Meeting (“SGM”) in accordance with section 3 of the Company’s Bye-Laws shall be held on Thursday, October 17, 2013 at 10:00 am in Kreugersalen at Tändstickspalatset, Västra Trädgårdsgatan 15, in Stockholm, Sweden.

Notice to attend etc.

Holders of depository receipts wishing to attend the General Meeting shall:

(1)     be listed in the register of holders of depository receipts kept by Euroclear Sweden AB on Friday, October 11, 2013; and

(2)     notify the Company of the intention to attend the General Meeting not later than Tuesday, October 15, 2013 by mail at the address General Meeting, Vostok Nafta Sverige AB, Hovslagargatan 5, 3rd floor, SE-111 48 Stockholm, Sweden, by telephone +46 8 545 015 50, by fax +46 8 545 015 54 or by e-mail to sgm2013@vostoknafta.com. The holder of depository receipts shall state name, personal or company identification number, address as well as telephone number. If a holder of depository receipts intends to be represented by proxy, the name of the proxy holder shall be stated.

Holders of depository receipts who hold their receipts through nominees (Sw. förvaltare) must request a temporary registration of the voting rights in order to be able to participate at the General Meeting. Holders of depository receipts who wish to obtain such registration must contact the nominee regarding this well in advance of Friday, October 11, 2013. Proposed agenda

1.   Election of Chairman for the Meeting.

2.   Preparation and approval of voting list.

3.   Approval of the agenda.

4.   Election of one or two persons to check and sign the minutes.

5.   Resolution that the Meeting has been duly convened.

6.   Determination of the number of Directors.

7.   Determination of remuneration to the Directors.

8.   Election of Directors.

9.   Closing of the Meeting.

Election of Directors etc. (Items 6-8):

The Nomination Committee proposes that the Board of Directors shall consist of four Directors.

The Nomination Committee proposes, for the period until the next Annual General Meeting, the re-election of Per Brilioth and Lars O Grönstedt and the new election of Josh Blachman and Keith Richman. The Nomination Committee proposes that the Meeting appoint Lars O Grönstedt as Chairman of the Board.

The Nomination Committee proposes a total Board remuneration of SEK 1,300,000, of which SEK 800,000 shall be allocated to the Chairman of the Board and SEK 250,000 to each of the other Directors who are not employed by the Company. The Nomination Committee does not envisage Board Committees. The Nomination Committee proposes that Directors who so wish be permitted to invoice the Company for their Board fees in an amount that is cost neutral to the Company, provided any Director who does so is solely liable for any tax effects.

A brief description of the proposed new Directors is set out below:

Josh Blachman, US citizen, born 1974. Professional and educational background: Josh Blachman has worked at the intersection of technology, finance and investing in a variety of capacities since 1998. He is co-founder and Managing Director of Atlas Peak Capital and has been a Vice President at Saints Capital where he completed a variety of investments in private technology companies. Previously, Josh Blachman worked in the Corporate Development groups at Microsoft and then Oracle where he evaluated and executed both acquisitions and investments. Josh Blachman holds Bachelor and Master of Science degrees in Industrial Engineering from Stanford University and an MBA from the Stanford Graduate School of Business.

Keith Richman, US citizen, born 1973. Professional and educational background: Keith Richman is Founder and Chief Executive Officer of Break Media, an Internet entertainment community for men. Prior to co-founding Break Media, Keith Richman was the Co-Founder and Vice-President of OnePage (acquired by Sybase 2002) and Co-Founder and Director of Business Development for Billpoint Inc. (acquired by eBay in 1999). Previous posts include Director of Corporate Planning at the Walt Disney Company, where he focused on consumer products, cable and emerging media. Keith Richman holds Bachelor and Master of Arts degrees in International Policy Studies from Stanford University.

Stockholm, September 27, 2013

PARETO SECURITIES AB     

THE BOARD OF DIRECTORS OF VOSTOK NAFTA INVESTMENT LTD

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of $100 Investment in TD Synnex - A 20-Year Review

Updated Category News Views 201

Understanding the Value of Long-Term Investments Investing can often feel daunting, but the story of TD Synnex (NYSE: SNX) illustrates the powerful potential of long-term commitment. Over the last two decades, the company's stock has outperformed the broader market, delivering compelling returns to its investors. The Journey of TD Synnex Over the Past 20 Years During this...

Continue Reading
Growth of Nuclear Medicine Software Market Expected to Surge

Updated Category News Views 101

Emerging Trends in the Nuclear Medicine Software Market The nuclear medicine software market is poised for significant growth, projected to reach approximately US$1,491.55 million by 2030. This represents a compound annual growth rate (CAGR) of 9.0% from its current valuation. As healthcare continues to evolve, the demand for precise and early diagnostics is paramount,...

Continue Reading
Quanterix Corporation Faces Investigation Amid Investor Concerns

Updated Category News Views 400

Quanterix Corporation Faces Scrutiny from Rosic Law Firm In a recent development, Quanterix Corporation (NASDAQ: QTRX) has come under investigation by the Rosen Law Firm. This esteemed global investor rights law firm is exploring potential securities claims on behalf of the company's shareholders. The investigation arises from allegations of misleading business...

Continue Reading
Navigating Market Dynamics: Strategies for Today's Investors

Updated Category News Views 139

Understanding Market Strategies To excel in today's stock market, it's essential to have a keen understanding of various investment strategies. The current landscape suggests that savvy investors can find profitable opportunities even amid volatility. Taking Advantage of Hedges In light of recent sell-offs, a prudent strategy involves taking partial profits on hedges....

Continue Reading
Celebrate the Magic of Middle-earth: A Unique Reunion Tour

Updated Category News Views 246

FAN EXPO Celebrates 25 Years of The Lord of the Rings FAN EXPO HQ is thrilled to announce a special celebration marking the 25th anniversary of the iconic film, The Lord of the Rings. This memorable event, titled An Evening with the Hobbits: In Celebration of 25 Years, will take place in 11 cities across North America, starting in January. Key cast members Elijah Wood,...

Continue Reading